31.8.2013
EN
Official Journal of the European Union
C 252/32
Action brought on 17 June 2013 — Endoceutics/OHIM — Merck (FEMIVIA)
(Case T-324/13)
2013/C 252/53
Language in which the application was lodged: English
Parties
Applicant: Endoceutics, Inc. (Quebec, Canada) (represented by: M. Wahlin, lawyer)
Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)
Other party to the proceedings before the Board of Appeal: Merck KGaA (Darmstadt, Germany)
Form of order sought
The applicant claims that the Court should:
—
Annul the decision of the Fourth Board of Appeal of the OHIM of 15 April 2013, in Case R 1021/2012-4;
—
Reject the opposition of the other party and allow registration of the Community trade mark applied for, namely the application for the mark FEMIVIA under application No. 9 386 343;
—
Order the other party to pay the applicant’s costs on the appeal and regarding the proceedings before the OHIM.
Pleas in law and main arguments
Applicant for a Community trade mark: The applicant
Community trade mark concerned: The word mark ‘FEMIVIA’, for goods in class 5 — Community trade mark application No 9 386 343
Proprietor of the mark or sign cited in the opposition proceedings: The other party to the proceedings before the Board of Appeal
Mark or sign cited in opposition: Community trade mark of the word mark ‘FEMIBION’, for goods in class 5 and International registration with effect in the European Union for the figurative mark in black and white ‘femibion’ for goods of classes 5 29 and 30
Decision of the Opposition Division: Rejected the opposition
Decision of the Board of Appeal: Annulled the contested decision and rejected the CTM application in its entirety
Pleas in law: Infringement of Article 8(1)(b) of Council Regulation No 207/2009.
Full & Egal Universal Law Academy